Acute pericarditis
Overview
Acute pericarditis is inflammation of the pericardium lasting <4-6 weeks, accounting for ~5% of ED non-ischaemic chest pain presentations. Mostly idiopathic/viral (~90%). Key clinical importance: mimics ACS on ECG but managed differently.
Aetiology
•Idiopathic/viral (~90%) - Coxsackievirus B, echovirus, CMV, EBV
•Post-cardiac injury - early post-MI fibrinous pericarditis (1-3 days); Dressler's syndrome (weeks-months post-MI/cardiac surgery)
•TB - predominant cause in developing countries
•Uraemic - indication for emergency dialysis
•Autoimmune - SLE, rheumatoid arthritis, sarcoidosis
•Malignancy - lung, breast, Hodgkin's lymphoma
Presentation
•Chest pain - sharp, pleuritic, retrosternal; relieved by sitting forward, worse lying supine
•Pericardial friction rub - scratching, high-pitched at left sternal edge; best heard leaning forward in held expiration; pathognomonic but evanescent
•Fever - low-grade (viral); high fever suggests bacterial
•Referred left shoulder tip pain - via phrenic nerve (C3-C5)
•Viral prodrome - preceding URTI, myalgia, malaise
Investigations
•ECG - diffuse saddle-shaped (concave) ST elevation, PR depression (most leads), PR elevation in aVR
•CRP/ESR/FBC - confirms active inflammation; CRP used to guide colchicine duration
•Troponin - mild elevation acceptable; significant rise suggests myopericarditis
•Echocardiogram - assesses effusion, wall motion, ventricular function; recommended in all confirmed/suspected cases
•CXR - usually normal; 'flask-shaped' enlarged cardiac silhouette if effusion >250 mL
Acute pericarditis vs STEMI on ECG
| Feature | Pericarditis | STEMI |
|---|---|---|
| ST elevation shape | Diffuse, concave (saddle-shaped) | Localised to territory, convex (dome-shaped) |
| PR depression | Present (highly specific) | Absent |
| Reciprocal ST depression | Absent (except aVR) | Present in opposite leads |
| Pathological Q waves | Absent | May develop |
Management
•High-risk features requiring hospitalisation: fever >38°C, subacute onset, large effusion, cardiac tamponade, failure to respond to NSAIDs after 1 week, immunocompromise, oral anticoagulant use, trauma, suspected myopericarditis
🥇 First-line
•ibuprofen 600 mg three times daily (or aspirin 750-1000 mg three times daily if post-MI) - continue until CRP normalises, then taper
•Add: colchicine 0.5 mg twice daily (0.5 mg once daily if <70 kg or intolerant) for 3 months - reduces recurrence by ~50%
•Gastroprotection: omeprazole 20 mg once daily co-prescribed with NSAIDs
🥈 Second-line
•prednisolone (low-moderate dose) - only if NSAIDs contraindicated or steroid-responsive cause (SLE, uraemic pericarditis)
🥉 Third-line
•anakinra (IL-1 receptor antagonist) or azathioprine - refractory/recurrent disease, specialist input required
•Activity restriction - avoid strenuous activity until symptoms resolve and CRP normalises; competitive athletes restricted for at least 3 months
•Cause-specific: uraemic pericarditis - urgent dialysis; TB pericarditis - antituberculous therapy; bacterial - IV antibiotics ± surgical drainage
Complications
•Pericardial effusion - inflammatory exudate; large effusions cause haemodynamic compromise
•Cardiac tamponade - raised intrapericardial pressure → reduced cardiac output; Beck's triad: muffled heart sounds, hypotension, raised JVP; requires urgent pericardiocentesis
•Recurrent pericarditis - 15-30% after first episode; managed with NSAIDs, colchicine, ± immunosuppression
•Constrictive pericarditis - chronic fibrotic thickening → impaired diastolic filling; rare (<1%) with viral cause but more common with bacterial/TB; presents with right heart failure features
•Myopericarditis - extension into myocardium; more common in young men; disproportionate troponin elevation, risk of arrhythmias
Diagnostic criteria (ESC 2015)
At least 2 of the following 4 criteria required:
1.Pleuritic chest pain (positional, sharp)
2.Pericardial friction rub
3.ECG changes: new widespread saddle-shaped (concave) ST elevation or PR depression
4.Pericardial effusion (new or worsening) on echocardiogram